20mg bpc 157 BPC-157 + TB-500 | UK Research Blend, ≥99% HPLC BPC-157/TB-500 BLEND 20MG (BPC-157 10mg/TB-500

What Are the Theoretical Risks

Most of what is known comes from: So when someone searches for BPC 157 weight loss, it is important to set expectations right away: this is not comparable to clinically validated obesity therapies backed by decades of clinical outcome data, standardized dosing, and predictable effects on appetite and metabolic pathways, such as FDA-approved options like semaglutide (Wegovy) and tirzepatide (Zepbound)

Journal (Journal of Physiology and Pharmacology, Dec 2009, 60 Suppl 7, 191196)

The phase 2 trial is expected to start in the second half of 2024, providing more data on its effectiveness and safety